WO2008022953A1 - Verfahren zur herstellung von d,l-2-hydroxy-4-alkylthiobuttersäuren - Google Patents
Verfahren zur herstellung von d,l-2-hydroxy-4-alkylthiobuttersäuren Download PDFInfo
- Publication number
- WO2008022953A1 WO2008022953A1 PCT/EP2007/058426 EP2007058426W WO2008022953A1 WO 2008022953 A1 WO2008022953 A1 WO 2008022953A1 EP 2007058426 W EP2007058426 W EP 2007058426W WO 2008022953 A1 WO2008022953 A1 WO 2008022953A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compounds
- butyrolactone
- reaction
- hydroxy
- Prior art date
Links
- 0 *=C(CCO1)C1=* Chemical compound *=C(CCO1)C1=* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
Definitions
- the present invention relates to a process for the preparation of compounds of the formula (I)
- R is C to C 6 alkyl
- the present invention relates to a process for the preparation of compounds of the formula (II)
- Methionine and methionine hydroxy analogue are among the economically most important amino acids in addition to L-glutamic acid and L-lysine.
- Methionine is an essential sulfur-containing amino acid whose metabolically active form is S-adenosyl-methionine (SAM).
- SAM S-adenosyl-methionine
- methionine D, L-2-amino-4-methylthiobutyric acid
- the body is able to convert the D-shape completely into the active L-shape.
- the configuration of the ⁇ -amino group is irrelevant.
- MHA methionine hydroxyanalogone
- D L-2-hydroxy-4-methylthiobutyric acid
- MHA methionine hydroxyanalogone
- the amino group of methionine is substituted by a hydroxyl group.
- the conversion takes place in the active L-form of methionine.
- racemic MHA represents a complete replacement for methionine.
- the methods for the preparation of methionine and MHA in feed quality are based essentially on the educts acrolein, methylmercaptan and hydrocyanic acid.
- a process described in DE 1 906 405 starts with acrolein and mercaptan in a first step, which are converted to 3-methylmercaptopropionaldehyde (MMP). This is in a next step with hydrocyanic acid and ammonium hydro- gencarbonat converted to a hydantoin, which is then reacted alkaline to D, L-potassium methionate. Acidification yields D, L-methionine.
- MMP 3-methylmercaptopropionaldehyde
- DE 840 996 discloses a process for preparing thioethercarboxylic acids.
- unsubstituted lactones or lactones with aromatic radicals such as phthalides or coumarins with alkali metal or alkaline earth metal compounds mercapto compounds are heated, which contain no unesterified carboxyl groups.
- the reaction takes place without addition of solvent, if appropriate with an excess of lactone as solvent or in the presence of inert solvents such as benzene, toluene or decalin.
- the object was to find, starting from less toxic starting materials, a cost-effective production process of D, L-2-hydroxy-4-alkylthiobutyric acid of the formula (I)
- the object was to find, starting from less toxic starting materials, a cost-effective production process of MHA of the formula (Ia)
- the object has been achieved by providing a process for preparing compounds of the formula (I),
- RSM that is the reaction of compounds of the formula with thiolates RSM includes.
- R means according to the invention d- to C ⁇ -alkyl.
- These are, for example, methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1, 1-dimethylethyl, n-pentyl, 1-methyl-butyl, 2-methylbutyl, 3-methylbutyl , 2,2-dimethylpropyl, 1-ethylpropyl, 1, 1-dimethylpropyl, 1, 2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1, 1-dimethylbutyl, 1 , 2-dimethylbutyl, 1, 3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,
- the residues may also contain one or more stereocenters.
- R is C 1 to C 4 alkyl. These are, for example, methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1, 1-dimethylethyl and mixtures thereof.
- the radicals may contain at least one stereogenic center.
- M is alkali metal, alkaline earth metal, Fe, Zn or a mixture thereof.
- Alkali metal is Li, Na, K, Rb, Cs or a mixture thereof.
- Alkaline earth metal is Be, Mg, Ca, Sr, Ba, or a mixture thereof.
- n is equal to 1.
- n is 2. In the case where M is Fe, n is 2 and / or 3.
- M is Li, Na, K or a mixture thereof, preferably n is equal to 1.
- M which may be alkaline earth metal, Zn or Fe, the radicals R of the corresponding thiolate (RS) n M may be the same or different.
- Thiolates of the formula (RS) n M with identical or different radicals R and / or identical or different metals M may be used simultaneously.
- the meandering line represents an S or R configuration at the associated carbon atom.
- a formula containing a meandering line preferably represents any mixture, more preferably a racemic mixture, of the enantiomeric forms of the compound. Alternatively, such formula may stand for a particular unspecified enantiomeric form.
- a carbon atom with four different substituents is a stereocenter. If a molecule has exactly one stereocenter, two different configurations of the corresponding molecule are possible. The two unrelated mirror-image forms of such a molecule are referred to as enantiomers. According to the rules of Cahn, Ingold and Prelog, a distinction is made between R and S enantiomers.
- racemate A mixture with equal proportions of both enantiomers is called racemate or racemic mixture.
- the molar ratio and the weight ratio of the two enantiomers in the racemate are the same because of the identical molecular mass of the enantiomers.
- the thiolates (RS) n M can be used as solutions.
- the concentration of thiolates (RS) n M is typically 10% by weight or more, preferably 20% by weight or more. It is also possible to use solutions having a concentration of 50% by weight or more, preferably 90% by weight or more.
- the thiolates (RS) n M can be used in particular as a solution in the corresponding thiol (RS) n H.
- An advantage according to the invention is that the stereoisomerism of the cyclic ester group ⁇ -containing hydroxy group of the compounds of the formula (II) is retained in the preparation of the compounds of the formula (I).
- compounds of formula (II) racemic mixtures, so that the correspondingly obtained compounds of formula (I) are racemic mixtures.
- Another preferred embodiment of the present invention is that one of the stereoisomeric forms is substantially predominant.
- the enantiomeric excess of the isomer mixture used is preferably at least 90% ee.
- the enantiomeric excess is defined as
- the compound of the formula (II) is employed in enantiomerically pure form.
- the process of the invention is preferably carried out in polar aprotic solvents.
- a polar solvent generally has a permittivity value of 10 or more, preferably 20 or more, more preferably 40 or more, at a temperature of 293.2K.
- a solvent is said to be aprotic if it is not or only with difficulty capable of cleaving off protons, since it either contains no hydrogen atoms or the hydrogen bonds have a high covalent character.
- a measure of the cleavability of protons from compounds is the acidity K 5 . This is determined in water unless otherwise specified. Usually the negative decadic logarithm of the acidity, the pK s value, is given.
- An aprotic solvent generally has a pK s value at a temperature of 293.2 K or, in the case of several possible cleavable protons, a lowest pK s value of 20 or more, preferably 22 or more, more preferably from 24 or more.
- Solvents can be used neat or as a mixture.
- Polar aprotic solvents may be mixed with other solvents, e.g. polar protic solvents or apolar solvents.
- the proportion of the other solvent (s) on the solvent mixture usually does not exceed 10% by weight.
- Preferred solvents to be used according to the invention are, for example, dimethylsulfoxide, N-methylpyrrolidone or mixtures thereof.
- the inventive method is carried out at temperatures that ensure a sufficiently rapid flow of the reaction.
- the reaction is conveniently carried out at temperatures of 50 0 C to 200 0 C.
- these are preferably made of ⁇ -butyrolactone (form old.
- ⁇ -Butyrolactone is available in large quantities as part of the value chain of the so-called Reppe chemistry. Starting from acetylene and formaldehyde, ⁇ -butyrolactone is obtained via the intermediates 1, 4-butynediol, 1, 4-butenediol and 1, 4-butanediol.
- the process according to the invention for the preparation of compounds of the formula (I) comprises a preceding process step in which ⁇ -butyrolactone is converted into compounds of the formula (II).
- a further object of the invention is a process in which ⁇ -butyrolactone of the formula (III) is first reacted to give compounds of the formula (IV) and the compounds of the formula (IV) are reacted in a subsequent step to give compounds of the formula (II)
- the rest X denotes according to the invention a halogen atom.
- a compound of the formula (IV) may always contain the same radical X or different radicals X.
- Halogen means according to the invention fluorine, chlorine, bromine and / or iodine. Preference is given to chlorine or bromine. Particularly preferred is chlorine.
- the compounds of the formula (II) are obtained by reacting ⁇ -butyrolactone with Formula (III) is first reacted to compounds of formula (IV) and the compounds of formula (IV) are reacted in a subsequent step to compounds of formula (II).
- ⁇ -Bromo- ⁇ -butyrolactone can be obtained by reaction of bromine Br2 with ⁇ -butyrolactone at about 100 0 C in the presence of phosphorus tribromide PBr3.
- the bromine compound obtained is optionally isolated, but preferably not isolated and immediately reacted with barium hydroxide to give ⁇ -hydroxy- ⁇ -butyrolactone.
- barium hydroxide is used as Ba (OH) 2-8H2 ⁇ .
- Phosphrtribromide is preferably used in amounts of from 1 to 20 mol%, more preferably from 5 to 15 mol%, based on ⁇ -butyrolactone.
- phosphorus tribromide is used in an amount of 10 mol%, based on ⁇ -butyrolactone.
- Phosphorus tribromide is usually added at temperatures of -10 to +10 0 C to ⁇ -butyrolactone.
- a suitable solvent is present, preferably no solvent is present.
- Bromine is also generally added at a temperature of -10 to + 10 0 C. Bromine is usually used in amounts of from 100 to 150 mol%, preferably from 110 to 140 mol%, based on ⁇ -butyrolactone.
- bromine is used in an amount of 130 mol%, based on ⁇ -butyrolactone.
- the reaction mixture is usually maintained for a period of time, e.g. heated for one to ten hours.
- the temperatures are usually in the range of 80 to 150 ° C.
- excess bromine is reduced after the reaction. This happens, for example, by adding NaHS ⁇ 3 solution.
- ⁇ -chloro- ⁇ -butyrolactone from ⁇ -butyrolactone by chlorination without the addition of a catalyst at elevated temperatures, for example, 100-200 0 C, preferably 140-160 0 C amount can be obtained.
- by-products may arise ⁇ , ⁇ -dichloro- ⁇ -butyrolactone and 2,4-dichlorobutyric acid.
- the 2,4-dichlorobutyric acid is preferably not separated off for the further reaction, since in the alkaline hydrolysis the cyclic form of the ⁇ -hydroxy- ⁇ -butyrolactone is formed again.
- the ⁇ , ⁇ -dichloro- ⁇ -butyrolactone can preferably be removed by distillation.
- Chlorine is usually used in amounts of from 100 to 150 mol%, preferably from 110 to 140 mol%, based on ⁇ -butyrolactone. In a particularly preferred embodiment, chlorine is used in an amount of 130 mol%, based on ⁇ -butyrolactone.
- the distillation preferably takes place at a reduced pressure, for example an absolute pressure of 1 mbar or less, preferably at 10 "1 mbar or less, more preferably 10" 2 mbar or less, instead.
- the product is distilled several times.
- reaction conditions for the treatment of ⁇ -chloro- ⁇ -butyrolactone with barium hydroxide are analogous to those for the treatment of ⁇ -bromo- ⁇ -butyrolactone with barium hydroxide.
- All processes according to the invention can be carried out batchwise, semicontinuously or continuously at different scales.
- the product in batch processes in quantities of 1 g to 1000 tons per batch, preferably 100 kg to 10 tons or in continuous processes with throughputs of 1 g to 1000 tons per hour, preferably 100 kg to 10 tons per hour.
- Special designs are the laboratory scale, the pilot plant scale, the pilot plant scale and the production scale.
- the starting materials are fed under the conditions mentioned to a suitable container and reacted there.
- the resulting product remains in the reactor. If necessary, it can be further purified there. Alternatively, it may be transferred to other suitable containers such as distillation columns and further purified there.
- the starting materials under the conditions mentioned are fed to a suitable container and reacted there. The resulting product is meanwhile removed from the reactor and optionally further purified.
- Semicontinuous processes include continuous and discontinuous process steps.
- Suitable containers for the methods may be, for example, containers made of glass, steel or stainless steel, which are optionally coated.
- the containers are usually equipped with a matching stirring option such as magnetic stirrer or anchor stirrer.
- the containers can be heated in a suitable manner, for example by means of oil baths or heating mantles operated electrically or with steam.
- the containers are chosen to withstand the temperature and pressure conditions prevailing in the reaction. Purification can be carried out in a known manner, for example by distillation. If appropriate, unreacted starting material is recycled at a suitable point in the process.
- the present invention provides easy access to D, L-2-hydroxy-4-alkylthiobutyric acids such as MHA, one of the most economically important amino acids. It can be used as inexpensive, readily available and non-toxic starting material ⁇ -butyrolactone, which is implemented in a few steps to the desired end product.
- the yield was determined by weighing.
- the purity of the product was analyzed by 1 H-NMR.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/438,192 US20090318715A1 (en) | 2006-08-24 | 2007-08-15 | Method for the Production of D,L-2-Hydroxy-4-Alkylthio Butyric Acid |
JP2009525025A JP2010501516A (ja) | 2006-08-24 | 2007-08-15 | D,l−2−ヒドロキシ−4−アルキルチオ酪酸の製造方法 |
MX2009001816A MX2009001816A (es) | 2006-08-24 | 2007-08-15 | Procedimiento para la produccion de acido d,l-2-hidroxi-4-alquilti o butirico. |
EP07802607A EP2054382A1 (de) | 2006-08-24 | 2007-08-15 | Verfahren zur herstellung von d,l-2-hydroxy-4-alkylthiobuttersäuren |
BRPI0717005-0A BRPI0717005A2 (pt) | 2006-08-24 | 2007-08-15 | Processo para preparar ácidos d,l-2-hidróxi-4-alquiltiobutíricos |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06119485.8 | 2006-08-24 | ||
EP06119485 | 2006-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008022953A1 true WO2008022953A1 (de) | 2008-02-28 |
Family
ID=38717316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/058426 WO2008022953A1 (de) | 2006-08-24 | 2007-08-15 | Verfahren zur herstellung von d,l-2-hydroxy-4-alkylthiobuttersäuren |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090318715A1 (de) |
EP (1) | EP2054382A1 (de) |
JP (1) | JP2010501516A (de) |
CN (1) | CN101506153A (de) |
AR (1) | AR062504A1 (de) |
BR (1) | BRPI0717005A2 (de) |
MX (1) | MX2009001816A (de) |
RU (1) | RU2009110264A (de) |
TW (1) | TW200819419A (de) |
WO (1) | WO2008022953A1 (de) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012049435A1 (fr) * | 2010-10-15 | 2012-04-19 | Adisseo France S.A.S. | Procede de preparation de la 2-hydroxybutyrolactone |
WO2016162712A1 (en) | 2015-04-07 | 2016-10-13 | Metabolic Explorer | Modified microorganism for the optimized production of 2,4-dihydroxyburyrate |
KR101799987B1 (ko) | 2016-11-15 | 2017-11-21 | 주식회사 씨원켐 | 2-하이드록시-감마-부티로락톤의 제조방법 |
EP4299560A1 (de) | 2022-07-01 | 2024-01-03 | AMINO GmbH | Verfahren zur produktion von alpha-hydroxyalkylthiophencarbonsäuren und derivaten davon |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011112649A1 (en) * | 2010-03-09 | 2011-09-15 | Novus International Inc. | Preparation of methionine or selenomethionine from homoserine via a lactone intermediate |
ES2875010T3 (es) | 2012-04-26 | 2021-11-08 | Adisseo France Sas | Procedimiento de producción de ácido 2,4-dihidroxibutírico |
EP2872640B1 (de) | 2012-07-11 | 2020-03-25 | Adisseo France S.A.S. | Verfahren zur herstellung von 2,4-dihydroxybutyrat |
CN103467424B (zh) * | 2013-08-22 | 2016-04-27 | 南京华安药业有限公司 | 一种2,5-二羟基戊酸delta内酯的合成方法 |
US10858675B2 (en) | 2015-04-07 | 2020-12-08 | Metabolic Explorer | Modified microorganism for the optimized production of 2,4-dihydroxybutyrate with enhanced 2,4-dihydroxybutyrate efflux |
JP6908529B2 (ja) * | 2015-04-30 | 2021-07-28 | ハルドール・トプサー・アクチエゼルスカベット | 糖およびその誘導体からのメチオニンα−ヒドロキシ類似体の製造方法 |
BR112017027815B1 (pt) | 2015-06-25 | 2021-12-21 | Dynamic Food Ingredients Corporation | Método de produção de 2,4-dihidroxibutirato |
FR3041659B1 (fr) | 2015-09-30 | 2017-10-20 | Arkema France | Procede de production de l-methionine |
FR3041658B1 (fr) | 2015-09-30 | 2017-10-20 | Arkema France | Procede de production de l-methionine |
MY198309A (en) | 2016-06-24 | 2023-08-22 | Novus Int Inc | Hydroxy methionine analog formulations suibtable for specialty chemical applications |
CN112876394A (zh) * | 2021-02-09 | 2021-06-01 | 中国科学院福建物质结构研究所 | 一种dl-羟基硒代蛋氨酸的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0245231A1 (de) * | 1986-05-08 | 1987-11-11 | Monsanto Company | Verfahren zur Herstellung von Alkylthioalkansäuresalzen |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4883911A (en) * | 1986-05-08 | 1989-11-28 | Monsanto Company | Process for the preparation of alkylthioalkanoate salts |
-
2007
- 2007-08-15 BR BRPI0717005-0A patent/BRPI0717005A2/pt not_active IP Right Cessation
- 2007-08-15 MX MX2009001816A patent/MX2009001816A/es not_active Application Discontinuation
- 2007-08-15 WO PCT/EP2007/058426 patent/WO2008022953A1/de active Application Filing
- 2007-08-15 RU RU2009110264/04A patent/RU2009110264A/ru not_active Application Discontinuation
- 2007-08-15 JP JP2009525025A patent/JP2010501516A/ja not_active Withdrawn
- 2007-08-15 EP EP07802607A patent/EP2054382A1/de not_active Withdrawn
- 2007-08-15 CN CNA2007800310699A patent/CN101506153A/zh active Pending
- 2007-08-15 US US12/438,192 patent/US20090318715A1/en not_active Abandoned
- 2007-08-23 TW TW096131282A patent/TW200819419A/zh unknown
- 2007-08-23 AR ARP070103752A patent/AR062504A1/es not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0245231A1 (de) * | 1986-05-08 | 1987-11-11 | Monsanto Company | Verfahren zur Herstellung von Alkylthioalkansäuresalzen |
Non-Patent Citations (1)
Title |
---|
E. SPÄTH, ET AL.: "Eine neue Synthese von Pregen-(9) und von Preganin (IX. Mitteil. über Peganin)", BERICHTE DER DEUTSCHEN CHEMISCHEN GESELLSCHAFT, vol. 69, no. 2, 5 February 1936 (1936-02-05), VERLAG CHEMIE, WEINHEIM, DE, pages 255 - 257, XP002460437 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012049435A1 (fr) * | 2010-10-15 | 2012-04-19 | Adisseo France S.A.S. | Procede de preparation de la 2-hydroxybutyrolactone |
FR2966150A1 (fr) * | 2010-10-15 | 2012-04-20 | Adisseo France Sas | Procede de preparation de la 2-hydroxybutyrolactone |
US8822706B2 (en) | 2010-10-15 | 2014-09-02 | Adisseo France S.A.S. | Method for preparing 2-hydroxybutyrolactone |
KR101813089B1 (ko) | 2010-10-15 | 2018-01-30 | 아디쎄오 프랑스 에스에이에스 | 2-하이드록시부티로락톤의 제조 방법 |
WO2016162712A1 (en) | 2015-04-07 | 2016-10-13 | Metabolic Explorer | Modified microorganism for the optimized production of 2,4-dihydroxyburyrate |
US10415062B2 (en) | 2015-04-07 | 2019-09-17 | Metabolic Explorer | Modified microorganism for the optimized production of 2,4-dihydroxybutyrate |
KR101799987B1 (ko) | 2016-11-15 | 2017-11-21 | 주식회사 씨원켐 | 2-하이드록시-감마-부티로락톤의 제조방법 |
EP4299560A1 (de) | 2022-07-01 | 2024-01-03 | AMINO GmbH | Verfahren zur produktion von alpha-hydroxyalkylthiophencarbonsäuren und derivaten davon |
WO2024002633A1 (en) | 2022-07-01 | 2024-01-04 | Amino Gmbh | Method for the production of alpha hydroxy-alkylthio carboxylic acids and derivatives thereof |
Also Published As
Publication number | Publication date |
---|---|
BRPI0717005A2 (pt) | 2013-10-08 |
TW200819419A (en) | 2008-05-01 |
EP2054382A1 (de) | 2009-05-06 |
AR062504A1 (es) | 2008-11-12 |
RU2009110264A (ru) | 2010-09-27 |
CN101506153A (zh) | 2009-08-12 |
JP2010501516A (ja) | 2010-01-21 |
MX2009001816A (es) | 2009-05-28 |
US20090318715A1 (en) | 2009-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008022953A1 (de) | Verfahren zur herstellung von d,l-2-hydroxy-4-alkylthiobuttersäuren | |
EP1976827B1 (de) | Verfahren zur herstellung von methionin aus homoserin | |
DE2721264C2 (de) | Verfahren zur Herstellung von Di-n-propylessigsäure und deren nichttoxischen Alkali- und Erdalkalimetallsalzen | |
WO2002010151A2 (de) | Verfahren zur herstellung von liponsäure und dihydroliponsäure | |
EP2173700B1 (de) | Verfahren zur herstellung von ketosäuren und deren derivaten | |
EP0370391A2 (de) | Verfahren zur Herstellung von 4,5-Dichlor-6-ethylpyrimidin | |
DE3132332C2 (de) | ||
DE19533881A1 (de) | Herstellung und Verwendung der reinen Enantiomere der 8-Chlor-6-sulfonyloxy-octansäuren und ihrer Alkylester und der reinen Enantiomere der 6,8-Dichlor-octansäure und ihrer Alkylester | |
EP1339705A2 (de) | Verfahren zur herstellung von liponsäure und dihydroliponsaüre | |
DE60314410T2 (de) | Verfahren zur herstellung von modafinil | |
WO2010012675A1 (de) | Verfahren zur herstellung von phenylalkan-1-olen | |
EP1902042B1 (de) | Verfahren zur herstellung von 3,4-dichlor-isothiazolcarbonsäure | |
EP0586987B1 (de) | Verbessertes Verfahren zur Herstellung von R/S-gamma-Liponsäure oder R/S-alpha-Liponsäure | |
DE10359636A1 (de) | Verfahren zur Abtrennung von Methylmercaptan aus Reaktionsgemischen | |
DE60127455T2 (de) | Verfahren zur herstellung von beta-ketonitrilverbindungen | |
DE2163677C3 (de) | Mercaptomethylpropandiole-(1,3) und deren Herstellung | |
DE2143643A1 (de) | Verfahren zur Herstellung von alpha-Dithiolen | |
EP0785187B1 (de) | Herstellung von Salzen der 6,8-Bis(amidiniumthio)-octansäure | |
EP0011855A1 (de) | Verfahren zur Herstellung von Alkylestern ungesättigter alpha-Hydroxycarbonsäuren | |
DE3031385A1 (de) | 1-hydroxypyrazol und verfahren zu seiner herstellung | |
DD281382A5 (de) | Verfahren zur herstellung von 4-alkoxy-2(5h)-thiophenonen | |
WO1996022272A1 (de) | Verfahren zur herstellung von optisch aktiven 2-halogenpropionsäuren | |
EP0653414A1 (de) | Verfahren zur Herstellung von Fluorbenzoesäurealkylestern durch Reaktion eines Fluorbenzoylchlorids mit einem Alkohol in Gegenwort eines Alkalimetallalkoholates | |
DE2836257A1 (de) | Verfahren zur herstellung von 2-substituierten 2-thioalkansaeurederivaten | |
DE2101359B2 (de) | Verfahren zur Herstellung von 4-Mercaptophenolen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780031069.9 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07802607 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2009/001816 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 701/KOLNP/2009 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009525025 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007802607 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2009110264 Country of ref document: RU Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12438192 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0717005 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090225 |